Emplicure Interim Report Q2 2022 - Great interest in our unique patented bioceramic technology

There is great interest in our unique patented bioceramic technology, which provides the opportunity to develop the next generation of nicotine pouches.

Second quarter, April-June 2022

  • Net sales amounted to MSEK 0.0 (0.1)
  • Operating loss (EBIT) amounted to MSEK -8.7 (-6.5)
  • Net loss amounted to MSEK -8.7 (-7.9)
  • Net cash flow amounted to MSEK +3.8 (-6.2)
  • EPS before and after dilution amounted to SEK -0.37 (-0.68)

January-June 2022

  • Net sales amounted to MSEK 0.0 (0.1)
  • Operating loss (EBIT) amounted to -16.0 (-7.5)
  • Net loss amounted to MSEK -16.0 (-9.3)
  • Net cash flow amounted to MSEK -1.7 (+3.3)
  • EPS before and after dilution amounted to SEK -0.73 (-0.80)

This information is information that Emplicure AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation. The informationen was submitted for publication, through the agency of the contact persons above, on August 18, 2022 at 08:30 CET.

For more information, please contact:

Torbjörn W. Larsson
CEO
Phone: +46 (0)70 747 65 99
Email: [email protected]

Erik Magnusson
CFO, Investor Relations
Phone: +46 (0)708 565 245
Email: [email protected]

Adviser
Emplicure AB (publ) is listed on the Nasdaq First North Growth Market. Certified Adviser is Mangold Fondkommission AB, +46 8 503 015 50, or via [email protected]

Emplicure develops new and innovative products by combining existing and approved active substances with advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain and on abuse-deterrent formulations. Wholly owned subsidiary Amplicon AB develops consumer products with oral nicotine as the first product. The share is listed on Nasdaq First North Growth Market (EMPLI). Read more at www.emplicure.com

Följ oss

Om beQuoted

beQuoted publicerar nyheter, analyser och pressmeddelanden för investerare och journalister. Viktiga företagshändelser bevakas av vår egen nyhetsredaktion och vidaredistribueras i ledande finansiella medier.

Vi uppdaterar även nyhetsrum, Investor Relations och IR-webbplatser för företag som vill utveckla sina relationer med finansmarknaden.

Kontakta oss

beQuoted AB
Nybrogatan 34
Box 5216
102 45 Stockholm

08-692 21 90

Om beQuoted